Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

movement may shift damage between organs and mimic lasting recovery

Suppressing while blocking may shift damage between organs, making early muscle improvement look like lasting recovery. Improvement across muscle, heart and lungs for months without transfer of the would refute this hypothesis.

Stage of verification

  1. Hypothesis published2026-09-30
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionImmune system

Ageing mechanism

Main connectionChronic inflammation

Direction

Kind of knowledge gap

The question is designed to try to disprove the leading explanation.Adversarial gap

A double ring marks the main placement where a group contains several values.

Lens
Compartmental outcome misattribution
Goal
Устойчивость восстановления к закреплению повреждённого состояния
Competing hypotheses
4
Published
2026-09-30
As a hypothesis
8 / 10Clarity of mechanism
10 / 10Few extra conditions
10 / 10Completeness of the answer
4 / 10Novelty of the idea
10 / 10Few new entities
6 / 10Decisive experiment
2 / 10Silver-bullet potential
4 / 10Support from research
Poster: Neutrophils redistribute damage across organs
PosterOpen the sheet full size2026-10-02

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Receptor or channel

    receptor

    A receptor whose activity can be suppressed

    Where this hypothesis actsDuring blockade of , with prolonged assessment of muscle, lung and heart function

    Hypotheses on this target 5
    EP2 receptorLower level. Hypotheses on this target 0Higher level. Hypotheses on this target 0Blockade. Hypotheses on this target 55Agonism. Hypotheses on this target 0Desensitisation. Hypotheses on this target 0Function restoration. Hypotheses on this target 0Function preservation. Hypotheses on this target 0
    • Lower level
    • Higher level
    • Blockade5
    • Agonism
    • Desensitisation
    • Function restoration
    • Function preservation

    What is proposed

    Blockade

    Suppress activity

    With whatNot stated in the record

    HowNot stated in the record

    Possible result

    Possible local functional improvement with redistribution of and delayed damage in other organs

    From the recordПодавление EP2 может действительно улучшать отдельные функции

  2. Immune response

    Efferocytosis

    The engulfment and clearance of apoptotic cells by phagocytes

    Where this hypothesis actsDuring , while tracking from their tissue of origin into blood and distant organs

    Hypotheses on this target 8
    EfferocytosisInhibition. Hypotheses on this target 55Activation. Hypotheses on this target 22Function preservation. Hypotheses on this target 0Clearance restoration. Hypotheses on this target 11Immunosuppression. Hypotheses on this target 0Feedback restoration. Hypotheses on this target 0Rhythm restoration. Hypotheses on this target 0
    • Inhibition5
    • Activation2
    • Function preservation
    • Clearance restoration1
    • Immunosuppression
    • Feedback restoration
    • Rhythm restoration

    What is proposed

    Inhibition

    Block

    With whatNot stated in the record

    HowNot stated in the record

    Possible result

    Expected persistence and redistribution of without sustained functional benefit across three systems

    From the recordПосле подавления EP2 на фоне блокады поглощения меченые нейтрофилы исчезают из исходной ткани, но сохраняются в крови и обнаруживаются в удалённых органах.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKαEP2 receptor. Hypotheses on this target 5EP2 receptor
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstructionEfferocytosis. Hypotheses on this target 8Efferocytosis
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

An early improvement in one organ can conceal damage appearing later somewhere else. The unexpected proposal is that suppressing while preventing other cells from swallowing could allow active to leave the improving tissue and carry damage elsewhere. This is a hypothesis generated by the pipeline, not a measured explanation of recovery.

The proposed mechanism, link by link
  1. is proposed to improve some local functions while swallowing remains blocked.
  2. Active are proposed to leave the original tissue instead of being swallowed and digested there.
  3. Departing are proposed to remain in blood and reach distant organs, redistributing damage rather than eliminating it.
  4. Early muscle improvement is proposed to precede lung or heart deterioration after repeated ordinary exertion.
  5. Separate measurements over an extended period are predicted to reveal no sustained, coordinated functional benefit across muscle, lungs and heart.
A picture for it

A room can look cleaner because its rubbish has been carried into other rooms. Inspecting only the first room, or inspecting the others before the rubbish arrives, mistakes relocation for cleanup.

Where the picture breaks: are active cells whose effects can change, not inert rubbish. The analogy cannot establish that departing cells damage their destination; the rival explanations also allow retained or their products to support protection.

  1. Master questionstep 01 of 04

    Aging processes may reinforce one another, so changing a shared cause might benefit several body systems at once.

    Rests on: The goal is to find a single with benefits across several systems rather than benefits confined to one.

    Assumption

    The search assumes that an accessible shared cause could produce benefits across several systems. The supplied material does not establish that such a target exists.

  2. Goal pillarstep 02 of 04

    Recovery should resist becoming locked into a damaged state.

    Rests on: The master question identifies mutually reinforcing aging processes as a possible reason damage persists and a shared might help.

    Stated in the chain
  3. Gap questionstep 03 of 04

    Lasting benefits across several systems might survive even when the recovery of removal is selectively prevented. Such persistence would challenge the claim that removal is the shared cause of improvement.

    Rests on: The preceding stage calls for durable recovery, but does not connect that goal to or explain why restored removal is the candidate shared cause.

    Leap

    The supplied chain does not provide the bridge from resistance to persistent damage to and restored removal of . The screened sources do not establish that removing whole causes lasting benefit across several systems.

  4. Hypothesisstep 04 of 04

    Apparent lasting recovery could instead combine genuine early muscle improvement with delayed lung or heart damage caused by departing . The proposal predicts that separate, extended measurements would reveal no sustained, coordinated improvement across all three systems.S5

    Rests on: The gap question supplies the setting: while swallowing is blocked. S5, a mouse study in Cell Death & Disease from 2024, reports evidence suggesting that a circulating signal draws away from inflammatory sites and might spread inflammation; it does not test or establish transfer between organs, delayed functional damage, or apparent lasting recovery.

    Supported by literature

What is carried, and what is not. Of the five proposed links listed here, one has direct background support in the supplied source excerpts: departure from an inflammatory site. S5 suggests such departure and possible spread of inflammation in mice, but neither it nor the other supplied excerpts establishes the full sequence from to cell redistribution, delayed organ damage and absence of lasting benefit.S5

Where the reasoning is carried by something unstated · 2
  • Master question. The search assumes that an accessible shared cause could produce benefits across several systems. The supplied material does not establish that such a target exists.
  • Gap question. The supplied chain does not provide the bridge from resistance to persistent damage to and restored removal of . The screened sources do not establish that removing whole causes lasting benefit across several systems. Establish the missing link before relying on this step.
How a result here could mislead · 3
  • A in a distant organ could be counted as an intact migrated when it is actually inside a , an immune cell that swallows cells and material. What closes it: The proposed tracking must distinguish intact from transferred to , and establish that the tracked cells originated in the specified tissue.
  • Early muscle improvement or an average inflammation measurement could be treated as recovery across the body while delayed lung or heart deterioration remains hidden. What closes it: Muscle, lung and heart function must be measured separately and repeatedly, including after the specified repeated ordinary exertion. The observation period and criteria for coordinated benefit must be fixed before results are examined; the supplied material gives no exact duration or numerical criteria.
  • Finding migrated alongside distant deterioration could be read as proof that the cells caused the damage. The proposed tracking establishes location and timing, but does not itself separate cell-mediated damage from another effect of treatment or blocked swallowing. What closes it: Attribution of damage to redistribution requires a comparison that separates the effect of cell movement from the effects of and blocked swallowing. Such a comparison is not specified in the supplied test.

What would make this wrong. Confirmed improvement of muscle, lung and heart function sustained for months during and verified blockade of swallowing, with no transfer of the burden to distant organs, would contradict the hypothesis's defining prediction. The supplied material specifies neither an exact number of months nor numerical thresholds for improvement or absence of transfer.

What it would change. If the hypothesis held, apparent benefit in several measurements would not be enough to identify a shared cause worth targeting for life extension: the work would have to establish that damage had been reduced across organs and over time. Persistence of an early benefit despite blocked swallowing would also fail, by itself, to disprove a causal role for removal. Even then, the supplied proposal would not establish longer life, benefits in humans, or a general explanation of aging; it does not specify the species for its proposed test.

Sources read · 7

4 literature searches, 7 full texts, 2 abstract-only; 9 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1Partly answers it

PGE2 inhibits neutrophil phagocytosis through the EP2R-cAMP-PTEN pathway. · Immunity, inflammation and disease · 2022

“The EP2 receptor antagonist AH‐6089 partially blocked the inhibition of neutrophil phagocytosis PGE2.”

Does not settle: Источник не оценивает миграцию нейтрофилов между органами, повреждение лёгких или сердца, длительные функциональные исходы, многосистемную пользу или показатель SPV_11.

S2Partly answers it

E-prostanoid 2 receptor signaling suppresses lung innate immunity against Streptococcus pneumoniae. · Prostaglandins & other lipid mediators · 2012

“Bacterial clearance and survival were significantly improved in vivo in EP2 −/− mice and it correlated with greater neutrophilic inflammation and higher lung IL-12 levels.”

Does not settle: Источник описывает мышиную модель пневмококковой пневмонии и не устанавливает длительные многосистемные последствия подавления EP2, перемещение активных нейтрофилов между органами, повреждение лёгких или сердца, функцию мышц либо изменение SPV_11.

S3BackgroundAbstract only

KRIT1-mediated regulation of neutrophil adhesion and motility. · The FEBS journal · 2023

“Altogether, we show that KRIT1 regulates neutrophil adhesion and migration, likely through regulation of integrin activation, which can lead to altered inflammatory responses in vivo.”

Does not settle: Источник не изучает подавление EP2, повреждение сердца или мышц, перенос повреждения между органами, длительные функциональные исходы либо SPV_11.

S5Partly answers it

Chemerin attracts neutrophil reverse migration by interacting with C-C motif chemokine receptor-like 2. · Cell death & disease · 2024

“These results suggest that circulating chemerin attracts neutrophils to leave inflammatory sites by interacting with CCRL2, which might involve in the dissemination of inflammation.”

Does not settle: This mouse study does not test EP2 inhibition, muscle, heart, or long-term multisystem functional decline; it does not establish that redistribution occurs between organs or that it mimics lasting recovery.

S7Background

Endogenous Ceramide 24:1 Constrains Th17-Driven Neutrophilic Inflammation by Antagonizing EP2 Signaling. · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026

“Mechanistically, Cer24:1 antagonizes the EP2–JAK2–STAT3 axis, thereby attenuating EP2‐driven STAT3 activation and restraining the Th17–neutrophil program.”

Does not settle: Источник не исследует блокаду поглощения нейтрофилов, перемещение нейтрофилов между органами, повреждение лёгких или сердца, длительную многосистемную пользу либо скорость функционального ухудшения SPV_11.

S8BackgroundAbstract only

Migration of neutrophils from blood to tissue: alteration of modulatory effects of prostanoid on superoxide generation in rabbits and humans. · Life sciences · 1997

“Furthermore, it can be concluded that neutrophils become less responsive to prostanoids in terms of fMLP-stimulated superoxide production in association with their migration from blood to tissue.”

Does not settle: Источник не изучает подавление EP2, перераспределение нейтрофилов между органами, повреждение лёгких или сердца, длительные функциональные исходы либо SPV_11.

S9Background

Intrauterine group A streptococcal infections are exacerbated by prostaglandin E2. · Journal of immunology (Baltimore, Md. : 1950) · 2013

“We observed that while GAS infection alone or PGE 2 injection alone did not significantly alter neutrophil populations, a significant increase in tissue neutrophils was observed when infected mice were treated with PGE 2 ( ).”

Does not settle: Источник описывает острое заражение матки стрептококком группы A у мышей и действие PGE2. Он не исследует подавление EP2, поглощение или выход нейтрофилов, перенос повреждения между органами, функции мышц, лёгких или сердца, а также длительную многосистемную динамику SPV_11.

The gap this hypothesis explains

Two live hypotheses pull in opposite directions here, and the field has not chosen between them.

Does suppressing a cell signal still benefit several body systems when improved removal of worn-out immune cells is blocked?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Сохранится ли , если избирательно воспрепятствовать восстановлению , и опровергнет ли такой результат как общее причинное звено?

What this question is asking

The question asks whether improved removal of worn-out , a type of immune cell, is necessary for benefits across several body systems. The suppresses signaling through E prostanoid receptor subtype 2 () in tissue-resident , immune cells that live in tissues and remove cellular material. The comparison is between suppression that allows removal to improve and the same suppression with that improvement selectively prevented. The question assumes that suppression improves both removal and several aspects of health in aged mice, while treating removal as a possible shared cause of those benefits. It also asks whether benefits persisting when improved removal is blocked would disprove that proposed causal explanation.

What the terms mean
E prostanoid receptor subtype 2 (EP2)
A cell receptor through which prostaglandin E2 sends signals. The question concerns reducing its signaling in tissue-resident ; the supplied sources report different consequences of this signaling in different settings.
Prostaglandin E2
A signaling molecule that acts through receptors including . In the supplied sources, its signaling is linked to increased removal of dying cells, impaired bacterial killing, and protection against scarring, so its effects cannot be reduced to a single beneficial or harmful role.
Neutrophils
A type of immune cell. The question concerns removal of worn-out , rather than their production or every function they perform.
Senescent neutrophils
The aged or worn-out named in S1's title. The supplied material does not specify how that state was identified or whether it matches the dying-cell states studied in the other sources.
Tissue-resident macrophages
Immune cells that reside in tissues and can ingest cells and other material. They are the cells whose signaling was reduced in S1.
Clearance
Removal of cells or other material from a tissue. Here, the proposed causal step is improved removal of ; reduced accumulation alone would not specify how that reduction occurred.
Programmed cell death
An organized process through which cells die. The dying cells ingested in S6 should not automatically be treated as equivalent to every described as senescent in S1.
Mitochondrial fitness
The functional condition of mitochondria, structures within cells involved in supplying usable energy. S1 reports preservation of this condition but the supplied quotation does not specify its measurement.
Inflammation
A tissue and immune response to injury or threats. Body-wide inflammation is one of S1's reported outcomes, while the question asks whether improved cell removal explains its reduction.
Cognitive decline and frailty
Cognitive decline means worsening abilities such as memory and thinking; frailty means increased vulnerability associated with reduced physical reserves. Both are outcomes named in S1, but their measurement criteria are not supplied.
Hydrogen peroxide
A reactive chemical involved in the bacterial-killing mechanism described in S5. That source links reduced production of it to impaired bacterial killing.
Scarring
Formation of fibrous tissue, also called fibrosis. S8 concerns a possible loss of protection against this process in the uterine lining.
Selective prevention
The question's assumed ability to stop improvement in removal while keeping effective and avoiding other changes that could explain the outcomes. The supplied sources do not establish that this separation was achieved.
Necessary and sufficient causes
A necessary step must occur for a particular benefit to occur under the stated conditions. A sufficient step can produce that benefit on its own; showing necessity does not establish sufficiency.
What the question takes for granted
Premise only partly supported
Suppressing improves clearance and condition in aged mice and produces benefits across several body systems, with clearance proposed as their common causal link.

are immune cells, and tissue-resident are cells that can remove them as they become worn out. The assumption is that reducing signaling through a receptor on these improves their condition and removal work, alongside benefits elsewhere in the body. If established, that connection would provide the starting point for asking whether improved removal is required for those benefits.

S1 directly reports that reducing signaling in aged mice preserved mitochondrial fitness and prevented several adverse outcomes. Its title identifies restored clearance of senescent as the subject, but the supplied abstract quotation does not detail that clearance result or establish its necessity for the broader benefits. S6 reports increased uptake of dying cells following activation in another setting, so a general claim that less signaling necessarily improves clearance is not supported. None of the supplied passages establishes clearance as the necessary common cause.S1S6

The same question asked without the part nothing read establishes:

  • In aged mice, do the benefits of reducing signaling persist when improved removal is selectively prevented?
  • Which benefits of reducing signaling in aged mice require improved removal?
What turns on the answer
  • Benefits persist across systems If improved removal were genuinely prevented while receptor suppression remained effective, persistent benefits would mean that this improvement was not necessary for those measured benefits under those conditions. That would challenge clearance restoration as their required common cause, while leaving possible contributions from existing clearance or other settings unresolved.
  • Benefits disappear across systems Under the question's assumption of selective interference, losing the benefits would support a requirement for improved removal. It would not by itself establish that removal is the sole cause or that improving removal alone is sufficient to produce those benefits.
  • Some benefits persist and others disappear Under the same selectivity assumption, the outcomes would differ in their dependence on improved removal. Clearance restoration could then explain some benefits without serving as a necessary common link for every measured system.
Why it matters

The proposed chain runs from reduced receptor signaling to improved removal of worn-out immune cells, then to less inflammation and better function across several body systems. If improved removal is necessary, blocking that improvement would interrupt the chain despite continued receptor suppression. If benefits persist, the proposed explanation would need to distinguish benefits that require improved removal from benefits that do not. Mistaking an accompanying change for a necessary cause would misidentify why the works; assuming that receptor suppression always helps would also overlook the opposing effects reported in other biological settings.

What is already established

улучшает и состояние у мышей, RL-1; необходимость для общего устойчивого эффекта отдельно не установлена.

What would have to be true

Воспаление и функции возвращаются в заданные диапазоны за дни или недели; сохраняют восстановление нескольких систем месяцами.

What is missing

Требуется разорвать предполагаемую причинную цепь и проверить, исчезает ли при сохранённом воздействии на .

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

Предполагаемая устойчивая при блокаде отсутствует как общий результат. может действительно улучшать отдельные функции, одновременно способствуя выходу активных из исследуемой ткани и в другой орган. Ранние измерения мышцы и усреднённые показатели воспаления объединяют местное улучшение с ещё не проявившимся ухудшением лёгких или сердца. Таким образом, причинная ошибка состоит в признании общим восстановлением. Стабилизация скорости функционального ухудшения SPV_11 при раздельной длительной оценке систем должна отсутствовать.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

После на фоне блокады поглощения исчезают из исходной ткани, но сохраняются в крови и обнаруживаются в удалённых органах. Раннее улучшение мышцы сопровождается отсроченным ухудшением лёгочной или сердечной функции после . За заранее заданный согласованного функционального выигрыша трёх систем нет. Подтверждённое улучшение всех трёх систем на протяжении месяцев при отсутствии переноса опровергает эту гипотезу.

Would tell it apart from at least one rival. The prediction specifies observable cell redistribution, sequential functional changes, and an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

Отслеживание клеток из конкретного и позволяют отличить переваривание от их перемещения. необходимо отделять от присутствия целых . и распределяют между .

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

После на фоне блокады поглощения исчезают из исходной ткани, но сохраняются в крови и обнаруживаются в удалённых органах. Раннее улучшение мышцы сопровождается отсроченным ухудшением лёгочной или сердечной функции после . За заранее заданный согласованного функционального выигрыша трёх систем нет. Подтверждённое улучшение всех трёх систем на протяжении месяцев при отсутствии переноса опровергает эту гипотезу.

  • What would separate them

    Delaying neutrophil uptake may preserve vesicle-mediated complement inhibition predicts: При подтверждённом и одинаковом исходном повреждении блокада дополнительно улучшает восстановление мышцы, сердца и лёгких. Этот дополнительный выигрыш исчезает при -специфическом выключении и возвращается после введения очищенных . Напротив, независимое ускорение при сохранённой ухудшает восстановление, если происходит до образования защитных . Простое сохранение пользы при блокаде поглощения для подтверждения этой гипотезы недостаточно.

  • What would separate them

    Vesicle removal may limit damage from elastase shielded against its natural inhibitor predicts: При блокаде эффект сохраняется только при снижении количества с активной . Возврат таких устраняет пользу; равное количество с этого не делает. При одинаковой активности против малый подавляет и восстанавливает функции эффективнее крупного . После отделения от поверхности исчезает.

  • What would separate them

    Suppressing a prostaglandin receptor may curb ferroptosis through itaconate predicts: При и блокаде функции улучшаются на фоне сопоставимых количества , активности и . Одновременно снижаются и гибель . устраняет этот выигрыш; прямое подавление в восстанавливает его при продолжающейся блокаде поглощения. Отсутствие увеличения после опровергает предложенную связь.

  • What would separate them

    Shared lipid synthesis in neutrophils and platelets may limit tissue damage predicts: Польза сохраняется при блокаде и сопровождается усилением образования из . устраняет этот эффект при сохранённых количестве , активности на и . Введение соответствующего продукта синтеза восстанавливает функции. Отсутствие зависимости от при подтверждённом его выключении опровергает гипотезу.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionWould tell it apart from at least one rivalTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.